Electroconvulsive Therapy Versus Aripiprazole Addition to Clozapine in Patients with Clozapine-Resistant Symptoms (EMECLO): A Protocol of a Single-Blind, Multicenter, Randomized-Controlled Feasibility Trial
The study has been approved by the Medical Research Ethics Committee of the Amsterdam University Medical Center, location AMC, and was registered on 1 May 2022 in the EU Clinical Trials Register (EudraCT) under the trial name 'EMECLO' (2021-006333-19).
Authors
- Selene Veerman
- Martin D. de Jonge
- Jan Bogers (ORCID: https://orcid.org/0000-0001-7273-0027)
- Daniela Cianci
- Jurjen J. Luykx (ORCID: https://orcid.org/0000-0002-6439-2774)
- Jim van Os (ORCID: https://orcid.org/0000-0002-7245-1586)
- John Enterman (ORCID: https://orcid.org/0000-0002-3545-5289)
- Dan Cohen (ORCID: https://orcid.org/0000-0003-1542-4255)
- G. W. J. Frederix (ORCID: https://orcid.org/0000-0002-0355-3466)
- Jasper B. Zantvoord (ORCID: https://orcid.org/0000-0002-6475-902X)
- Lieuwe de Haan (ORCID: https://orcid.org/0000-0002-3820-7926)
- Wiepke Cahn (ORCID: https://orcid.org/0000-0002-0482-8759)
- Laura M. E. Blanken (ORCID: https://orcid.org/0000-0002-8212-8475)
- Mariken B. de Koning (ORCID: https://orcid.org/0000-0001-9095-7428)
- Mike Veereschild
- Peter F.J. Schulte (ORCID: https://orcid.org/0000-0003-4931-3393)
- Bram W C Storosum (ORCID: https://orcid.org/0000-0002-0764-8745)
- Joris J. B. van der Vlugt-Molenaar
- Inge Horn
- Hans J. de Haas
- Manouk den Toom
- Martin Javadzadeh
Institutions
- University Medical Center Utrecht (NL)
- Maastricht University (NL)
- Parnassia Groep (NL)
- GGZ Noord-Holland-Noord (NL)
- Foundation Centrum '45 (NL)
- Antes (NL)
- GGZ Rivierduinen (NL)
- GGZ inGeest (NL)
- Refaja Ziekenhuis (NL)
- GGNet (NL)
- Arkin (NL)
- Reinier van Arkel (NL)
- Amsterdam University Medical Centers (NL)
- Pro Persona (NL)
Publication Details
- Journal
- Pharmacopsychiatry
- Published
- 2024-08-26
- DOI
- https://doi.org/10.1055/a-2364-4357
- Primary Topic
- Electroconvulsive Therapy Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- ZonMw